In BioCentury’s Finance Report, two more companies plan Hong Kong listings; Disc Medicine, Arctic raise cash

CervoMed and Cognition Therapeutics testing different therapeutic hypotheses in dementia with Lewy bodies

Plus: Agency approves Pfizer’s hemophilia A and B mAb, and label expansions for five products

Plus data from BioNTech, MediLink, Nurix, Aerovate and more

Plus: AbbVie licenses TL1A mAb from FutureGen for IBD, and updates from Takeda, Ascentage, Pfizer, ProFound and more

Plus: Fundraising by Avidity, Ultragenyx, ProKidney, Disc Medicine, Opthea and Replimmune

CEO of Novartis breaks down major data readouts for Scemblix and remibrutinib this week

Seeded by DCVC Bio, Avicenna’s machine learning tech is designed to find a clinical candidate in a haystack of theoretical compounds

Even with big price reductions, China’s national reimbursement list is a lure for drug developers around the globe